• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
What Labs Need to Know About MolDX®

What Labs Need to Know About MolDX®

by Michael Schubert, PhD | Aug 30, 2024 | CMS-lca, Coding-lca, Essential, Lab Industry Advisor, Reimbursement-lca

How the MolDX® program works, what it covers, and how it can support better test access, use, and reimbursement in the clinical lab

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Syndromes Without a Name Bring Labs an Uphill Battle

Syndromes Without a Name Bring Labs an Uphill Battle

by Michael Schubert, PhD | Aug 29, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Molecular Mysteries in the Blood

Molecular Mysteries in the Blood

by Michael Schubert, PhD | Aug 29, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet

The current landscape of molecular hematopathology—and what steps clinical labs can take to stay at the forefront of the discipline

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Benefits of Group A Streptococcus NAAT

The Benefits of Group A Streptococcus NAAT

by Tyler Radke, MLS(ASCP)CM | Apr 25, 2024 | Essential, Lab Industry Advisor, Operations-lca

Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

by Glenn S. Demby | Aug 26, 2022 | News, Open Content, Special Focus-dtet

For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.

« Older Entries
Next Entries »

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com